GlaxoSmithKline plc (GSKN) - Total Liabilities

Latest as of September 2025: MX$45.59 Billion MXN ≈ $2.62 Billion USD

Based on the latest financial reports, GlaxoSmithKline plc (GSKN) has total liabilities worth MX$45.59 Billion MXN (≈ $2.62 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore GSKN cash generation efficiency to assess how effectively this company generates cash.

GlaxoSmithKline plc - Total Liabilities Trend (2013–2024)

This chart illustrates how GlaxoSmithKline plc's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of GlaxoSmithKline plc to evaluate the company's liquid asset resilience ratio.

GlaxoSmithKline plc Competitors by Total Liabilities

The table below lists competitors of GlaxoSmithKline plc ranked by their total liabilities.

Company	Country	Total Liabilities
Accenture plc NYSE:ACN	USA	$32.78 Billion
Starbucks Corporation NASDAQ:SBUX	USA	$40.61 Billion
DBS GROUP ADR/4 SD 1 F:DEV	Germany	€828.57 Billion
Crowdstrike Holdings Inc NASDAQ:CRWD	USA	$6.61 Billion
Air Liquide SA PA:AI	France	€24.97 Billion
Vertex Pharmaceuticals Inc NASDAQ:VRTX	USA	$6.98 Billion
State Bank of India NSE:SBIN	India	Rs72.70 Trillion

Liability Composition Analysis (2013–2024)

This chart breaks down GlaxoSmithKline plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is GlaxoSmithKline plc worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.84	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.82	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.74	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how GlaxoSmithKline plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for GlaxoSmithKline plc (2013–2024)

The table below shows the annual total liabilities of GlaxoSmithKline plc from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	MX$46.38 Billion ≈ $2.67 Billion	+0.36%
2023-12-31	MX$46.21 Billion ≈ $2.66 Billion	-7.67%
2022-12-31	MX$50.05 Billion ≈ $2.88 Billion	-13.35%
2021-12-31	MX$57.76 Billion ≈ $3.32 Billion	-3.12%
2020-12-31	MX$59.62 Billion ≈ $3.43 Billion	-2.79%
2019-12-31	MX$61.34 Billion ≈ $3.53 Billion	+12.76%
2018-12-31	MX$54.39 Billion ≈ $3.13 Billion	+2.84%
2017-12-31	MX$52.89 Billion ≈ $3.04 Billion	-2.27%
2016-12-31	MX$54.12 Billion ≈ $3.11 Billion	+21.43%
2015-12-31	MX$44.57 Billion ≈ $2.56 Billion	+24.79%
2014-12-31	MX$35.72 Billion ≈ $2.06 Billion	+4.20%
2013-12-31	MX$34.27 Billion ≈ $1.97 Billion	--

About GlaxoSmithKline plc

MX:GSKN Mexico Drug Manufacturers - General

Market Cap

$109.41 Billion

MX$1.90 Trillion MXN

Market Cap Rank

#220 Global

#9 in Mexico

Share Price

MX$947.40

Change (1 day)

+0.00%

52-Week Range

MX$710.00 - MX$1041.90

All Time High

MX$1096.34